Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease

T E Rudenko1, E S Kamyshova1, M P Vasilyeva1

  • 1I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Terapevticheskii Arkhiv
|February 1, 2019
PubMed

Insights

Diastolic dysfunction (DD) affects about 40% of chronic kidney disease (CKD) patients, increasing with renal dysfunction. Age and declining kidney function are key risk factors for DD in CKD.

Area of Science:

  • Cardiology
  • Nephrology
  • Cardiorenal Medicine

Background:

  • Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity.
  • Diastolic dysfunction (DD) of the left ventricle (LV) is a common cardiac complication in CKD patients.
  • Understanding the prevalence and risk factors for DD in CKD is crucial for patient management.

Purpose of the Study:

  • To determine the frequency of left ventricular diastolic dysfunction (DD) in patients with chronic kidney disease (CKD).
  • To identify risk factors associated with the development of DD in CKD patients.
  • To explore the relationship between the severity of CKD and the incidence of DD.

Main Methods:

  • A cohort of 225 non-diabetic CKD patients (stage I-IV) was studied, divided into three groups based on glomerular filtration rate (GFR).
  • Transthoracic echocardiography was performed to assess cardiac function and structure.
  • Clinical data, including age, body mass index (BMI), and fibrinogen levels, were collected. Cystatin C levels were measured in a subset of patients.

Main Results:

  • Left ventricular hypertrophy (LVH) was observed in 38.7% of CKD patients.
  • Diastolic dysfunction (DD) of the hypertrophic type (type I) was diagnosed in 41.4% of patients.
  • The incidence of DD increased with decreasing GFR (30% in GFR 89-45, 40% in GFR 44-15, and 60% in GFR <15 ml/min/1.73 m2).
  • Independent predictors for DD included older age (OR 1.106) and higher BMI.
  • Patients with DD had higher BMI, lower GFR, and higher fibrinogen levels, with a higher likelihood of LVH.

Conclusions:

  • Diastolic dysfunction (DD) is prevalent in approximately 40% of CKD patients, with its frequency escalating as renal dysfunction progresses.
  • Cardiovascular risk factors such as advanced age and elevated BMI contribute to DD development in CKD.
  • Declining glomerular filtration rate (GFR) and associated left ventricular (LV) remodeling are significant factors in the pathogenesis of DD in CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
725
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
641
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
466
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
388
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
323